$0.99
5.71% today
Nasdaq, Apr 04, 08:42 pm CET
ISIN
NL0012661870
Symbol
IFRX
Sector
Industry

InflaRx N.V. Target price 2025 - Analyst rating & recommendation

InflaRx N.V. Classifications & Recommendation:

Buy
83%
Hold
17%

InflaRx N.V. Price Target

Target Price $9.17
Price $1.05
Potential
Number of Estimates 5
5 Analysts have issued a price target InflaRx N.V. 2026 . The average InflaRx N.V. target price is $9.17. This is higher than the current stock price. The highest price target is
$12.94 1,132.82%
register free of charge
, the lowest is .
A rating was issued by 6 analysts: 5 Analysts recommend InflaRx N.V. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the InflaRx N.V. stock has an average upside potential 2026 of . Most analysts recommend the InflaRx N.V. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 0.18 0.66
157.14% 265.89%
Net Margin -27,804.44% -6,748.81%
60.65% 75.73%

5 Analysts have issued a sales forecast InflaRx N.V. 2025 . The average InflaRx N.V. sales estimate is

$659k
Unlock
. This is
265.89% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.2m 1,100.06%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $180k 157.14%
2025
$659k 265.89%
Unlock
2026
$20.0m 2,934.94%
Unlock
2027
$65.7m 228.70%
Unlock
2028
$112m 70.95%
Unlock
2029
$181m 61.04%
Unlock

3 InflaRx N.V. Analysts have issued a net profit forecast 2025. The average InflaRx N.V. net profit estimate is

$-44.5m
Unlock
. This is
28.10% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-38.3m 38.08%
Unlock
, the lowest is
$-47.9m 22.60%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-50.0m 1.19%
2025
$-44.5m 11.19%
Unlock
2026
$-38.5m 13.41%
Unlock
2027
$-44.3m 15.20%
Unlock
2028
$-39.6m 10.78%
Unlock
2029
$-16.0m 59.68%
Unlock

Net Margin

2024 -27,804.44% 60.65%
2025
-6,748.81% 75.73%
Unlock
2026
-192.59% 97.15%
Unlock
2027
-67.49% 64.96%
Unlock
2028
-35.22% 47.81%
Unlock
2029
-8.82% 74.96%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.85 -0.75
1.19% 11.76%
P/E negative
EV/Sales 10.45

3 Analysts have issued a InflaRx N.V. forecast for earnings per share. The average InflaRx N.V. EPS is

$-0.75
Unlock
. This is
28.57% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.65 38.10%
Unlock
, the lowest is
$-0.81 22.86%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.85 1.19%
2025
$-0.75 11.76%
Unlock
2026
$-0.65 13.33%
Unlock
2027
$-0.75 15.38%
Unlock
2028
$-0.67 10.67%
Unlock
2029
$-0.27 59.70%
Unlock

P/E ratio

Current -1.00 44.75%
2025
-1.39 39.00%
Unlock
2026
-1.61 15.83%
Unlock
2027
-1.39 13.66%
Unlock
2028
-1.56 12.23%
Unlock
2029
-3.88 148.72%
Unlock

Based on analysts' sales estimates for 2025, the InflaRx N.V. stock is valued at an EV/Sales of

10.45
Unlock
and an P/S ratio of
107.03
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 38.22 134.30%
2025
10.45 72.67%
Unlock
2026
0.34 96.70%
Unlock
2027
0.10 69.58%
Unlock
2028
0.06 41.45%
Unlock
2029
0.04 38.01%
Unlock

P/S ratio

Current 391.61 69.77%
2025
107.03 72.67%
Unlock
2026
3.53 96.70%
Unlock
2027
1.07 69.58%
Unlock
2028
0.63 41.50%
Unlock
2029
0.39 37.91%
Unlock

Current InflaRx N.V. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Guggenheim
Locked
Locked
Locked Mar 26 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 21 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 07 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 16 2025
HC Wainwright & Co.
Locked
Locked
Locked Dec 20 2024
HC Wainwright & Co.
Locked
Locked
Locked Nov 15 2024
HC Wainwright & Co.
Locked
Locked
Locked Nov 11 2024
Analyst Rating Date
Locked
Guggenheim:
Locked
Locked
Mar 26 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 21 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 07 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 16 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Dec 20 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 15 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 11 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today